Friday, April 29, 2016 7:57:34 AM
Customers Release Ten New Consumer Products to Various Markets
LONDON, UNITED KINGDOM--(Marketwired - Apr 29, 2016) - Plandaí Biotechnology, Inc. (OTCQB: PLPL) ("Plandaí" or "the Company"), producer of the highly bioavailable Phytofare® catechin complex, today announced that April 2016 saw the company sell and ship 425 kilograms of product, representing approximately $60,000 in revenues. In addition, since January, Plandaí announced that customers have released to market a total of ten new branded consumer products that contain Phytofare®, which are being sold in Australia, Western Europe and Africa. Products containing Phytofare® should be on shelves in United States as early as May.
Callum Cottrell-Duffield, Vice President of Sales and Marketing for Plandaí Biotechnology, commented, "We are pleased that our month over month sales volumes continue to grow. While the numbers are not yet staggering, we are nearing operational break-even and expect to achieve this short-term goal in the coming few months. As it stands, sales in April alone nearly equaled the total sales volume for the entire first quarter. As we enter new markets, including the United States, South America and Asia, we anticipate that sales will continue expanding as market acceptance has been very favorable."
Addressing the benefits of Phytofare® over competing products, Mr. Cottrell-Duffield added, "Phytofare® is one of the few nutraceutical products that is backed by human clinical trials and the only one to our knowledge that compares its bioavailability against that of a generic extract. In the case of green tea, numerous studies have shown that its catechins have tremendous potential health benefits as an antioxidant, thermogenesis stimulator, and as an anti-viral. Being able to scientifically prove that Phytofare® can deliver ten times more of the active ingredients to your system, and then have those ingredients remain in the blood plasma at therapeutic levels for over 24 hours, is a seen as a huge advantage by our customers. They believe, and we heartily agree, that consumers will see the difference and start demanding that their supplements actually deliver on their claims."
"Our goal by the end of 2016," Mr. Cottrell-Duffield continued, "is to have monthly sales of two metric tons, at which point the Senteeko factory will be positioned to increase production so that sales can increase to four tons per month. As we start selling more Phytofare Ph2, which is Phytofare® entrapped in Pheroid®, this volume can further double, giving us the potential for eight tons per month."
Lingerie Fighting Championships Signs Broadcast Deal With Maybacks Global Entertainment • BOTY • Sep 26, 2024 9:00 AM
Maybacks Global Entertainment and Lingerie Fighting Championships Enter Into Broadcast And Revenue Sharing Agreement • AHRO • Sep 26, 2024 8:30 AM
North Bay Resources Commences Operations at Bishop Gold Mill, Inyo County, California; Engages Sabean Group Management Consulting • NBRI • Sep 25, 2024 9:15 AM
CEO David B. Dorwart Anticipates a Bright Future at Good Gaming Inc. Through His Most Recent Shareholder Update • GMER • Sep 25, 2024 8:30 AM
Cannabix Technologies and Omega Laboratories Inc. Advance Marijuana Breathalyzer Technology - Dr. Bruce Goldberger to Present at Society of Forensic Toxicologists Conference • BLOZF • Sep 24, 2024 8:50 AM
Integrated Ventures, Inc Announces Strategic Partnership For GLP-1 (Semaglutide) Procurement Through MedWell USA, LLC. • INTV • Sep 24, 2024 8:45 AM